Matthew Ruth - Jul 20, 2022 Form 4 Insider Report for OPIANT PHARMACEUTICALS, INC. (OPNT)

Role
Chief Commercial Officer
Signature
/s/ Matthew Ruth
Stock symbol
OPNT
Transactions as of
Jul 20, 2022
Transactions value $
-$11,512
Form type
4
Date filed
7/21/2022, 04:08 PM
Previous filing
Jun 29, 2022
Next filing
Mar 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OPNT Common Stock Sale -$11.5K -1.08K -3.5% $10.62 29.9K Jul 20, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
F2 This transaction was executed in multiple trades at prices ranging from $10.34 to $10.75. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.